We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Preventive eye care in people with diabetes is cost-saving to the federal government. Implications for health-care reform.
- Authors
Javitt, J C; Aiello, L P; Chiang, Y; Ferris, F L, 3rd; Canner, J K; Greenfield, S
- Abstract
Diabetic retinopathy, which leads to macular edema and retinal neovascularization, is the leading cause of blindness among working-age Americans. Previous research has demonstrated significant cost savings associated with detection of eye disease in Americans with type I diabetes. However, detection and treatment of eye disease among those with type II diabetes was previously thought not to be cost-saving. Our purpose was to estimate the current and potential federal savings resulting from the screening and treatment of retinopathy in patients with type II diabetes, based on recently available data concerning efficacy of treating both macular edema and neovascularization along with new data on federal budgetary costs of blindness.
- Publication
Diabetes care, 1994, Vol 17, Issue 8, p909
- ISSN
0149-5992
- Publication type
Journal Article
- DOI
10.2337/diacare.17.8.909